GleamWall
中文EN

VASO VASO Corp

Electromedical & Electrotherapeutic Apparatus · OTC · SEC CIK 839087 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-1.2%
TTM net income YoY-5.0%
TTM EPS YoY0.0%
Revenue 3-yr CAGR-5.9%
Net income 3-yr CAGR-40.6%

Margins

Gross margin68.2%
Operating margin-3.7%
Net margin3.6%
FCF margin—
EBITDA margin-2.3%

Returns

ROE8.3%
ROA2.9%
ROIC (approx.)—
Asset turnover0.82x

Leverage & solvency

Liabilities / assets62.8%
Debt / equity0.00x
Current ratio2.25x
Interest coverage—

Cash quality & payout

Operating cash flow / net income2.77x
Accruals ratio-5.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$89.10M$86.77M
Cost of revenue$34.42M$34.72M
Gross profit$54.67M$52.05M
R&D expense$728,000$851,000
SG&A expense$52.20M$48.98M
Operating income-$2.89M$285,000
Interest expense$25,000$4,000
Pretax income-$1.31M$1.28M
Income tax-$2.88M$326,000
Net income$1.57M$951,000
EBITDA-$2.03M$1.11M
EPS (basic)0.010.01
EPS (diluted)0.010.01
Weighted avg. shares (diluted)176.00M175.59M
Balance sheet
Cash & equivalents$34.08M$26.27M
Receivables—$916,000
Inventory$833,000$911,000
Current assets$58.56M$51.19M
PP&E, net$121,000$1.54M
Goodwill$1.23M$1.18M
Intangibles$1.25M$1.61M
Total assets$89.32M$82.94M
Current liabilities$36.85M$34.72M
Total liabilities$59.89M$55.24M
Shareholders' equity$29.43M$27.70M
Shares outstanding175.95M175.70M
Cash flow statement
Operating cash flow$9.27M$3.28M
Investing cash flow-$725,000$11.73M
Financing cash flow$248,000-$89,000
Depreciation & amortization$858,000$824,000
Stock-based compensation$33,000$54,000

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.